Adrian Cabrera

Director/Miembro de la Junta en

Kiniciti

Finance

Consumer Services

Technology Services

Perfil

Adrian Cabrera is currently a Principal at Welsh, Carson, Anderson & Stowe since 2022, and a Board Member at Kiniciti since 2021.
Mr. Cabrera completed undergraduate studies at Florida International University in 2013.

Cargos activos de Adrian Cabrera

Empresas	Cargo	Inicio
Welsh, Carson, Anderson & Stowe Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements.	Inversor de Capital Privado	01/07/2019
Kiniciti Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies	Director/Miembro de la Junta	01/01/2021

Todos los cargos activos de Adrian Cabrera

Formación de Adrian Cabrera.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Adrian Cabrera.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Welsh, Carson, Anderson & Stowe Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements.	Finance
Florida International University Florida International University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiniciti Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies	Technology Services